Why is Bliss GVS Pharma falling/rising?

As of 18-Jul, Bliss GVS Pharma Ltd is experiencing a price increase, currently at Rs 161.40, reflecting a rise of Rs 4.05 or 2.57%. The stock has shown strong performance today, outperforming its sector by 1.19% and reaching an intraday high of Rs 163, which is a 3.59% increase. Over the past week, the stock has gained 4.81%, and it has also demonstrated impressive returns over the last month at 15.37% and the last year at 44.69%. Despite these positive movements, it is important to note that the company's profits have declined by 19.5% over the past year, and while it has a low debt-to-equity ratio and a fair valuation, it is trading at a premium compared to its peers.
In the broader market context, Bliss GVS Pharma's short-term performance has significantly outpaced the benchmark, with the Sensex declining by 0.90% over the past week. This indicates that the stock is not only performing well in isolation but is also gaining traction relative to the overall market. The stock's liquidity is adequate for trading, and rising investor participation, as evidenced by a 6.36% increase in delivery volume, suggests growing confidence among investors. Overall, the combination of strong recent performance, positive investor sentiment, and a favorable comparison to the benchmark contributes to the stock's upward movement.